8
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Entità del Rischio e Prevenzioni delle Infezioni nelle Protesi d’Anca e Ginocchio

&
Pages 15-22 | Published online: 27 Oct 2016

References

  • AAOS Advisory statement. The Use of Prophylactic Antibiotics in Orthopaedic Medicine and the Emergence of Vancomycin-Resistant Bacteria. American Academy of Orthopaedic Surgeons. http://www.aaos.org/cgibin/print_hit_bold.pl/wordhtml/papers/advistmt/vancomyc.htm
  • Baird RA, Nickel FR, Thrupp LD, Rucker S, Hawkins B: Splash basin contamination in orthopaedic surgery. Clin Orthop 1984; 187: 129-133.
  • Bannister GC, Auchincloss JM, Johnson DP, Newmann JH: The timing of tourniquet application in relation to prophylactic antibiotic administration. J Bone Joint Surg 1988; 70-B: 322-324.
  • Beer KJ, Lombardi AV Jr, Mallory TH, Vaughn BK: The efficacy of suction drains after routine total joint arthroplasty. J Bone Joint Surg 1991; 73-A: 584-587.
  • Benjamin JB, Volz RG: Efficacy of a topical antibiotic irrigant in decreasing or eliminating bacterial contamination in surgical wounds. Clin Orthop 1984; 184: 114-117.
  • Branemark PI, Ekholm R: Tissue injury caused by wound disinfectants. J Bone Joint Surg 1967; 49-A: 48-62.
  • Bryan CS, Morgan SL, Caton RJ, Lunceford EM: Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty. Clin Orthop 1988; 228: 117-122.
  • Burke JF: The effective period of preventative antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-168.
  • Charnley J: A clean-air operating enclosure. Br J Surg 1964; 51: 202-205.
  • Charnley J, Eftekhar N: Postoperative infection in total prosthetic replacement arthroplasty of the hip joint with special reference to the bacterial content of the air in the operating room. Br J Surg 1969; 56: 641-649.
  • Charnley J: postoperative infection after total hip replacement with special reference to air contamination in the operating room. Clin Orthop 1972; 87: 167-187.
  • Chu CC, Williams DF: Effects of physical configuration and chemical structure of suture material on bacterial adhesion: A possible link to wound infection. Am J Surg 1984; 147: 197-204.
  • Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP: The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992; 326: 281-286.
  • Davies RR, Noble WC: Dispersal of bacteria on desquamated skin. Lancet 1962; 2: 1295-1297.
  • Debenedictis KJ, Rowan NM, Boyer BL: A double-blind study comparing cefonicid with cefazolin as prophylaxis in patients undergoing total hip or knee replacement. Rev Infect Dis 1984; (suppl 4): S901-S904.
  • Doyon F, Evrard J, Mazas F: An assessment of published trials on antibiotic prophylaxis in orthopaedic surgery. French J Orthop Surg 1989; 3: 49-53.
  • Dreblow DM, Anderson CF, Moxness K: Nutritional assessment of orthopaedic patients. Mayo Clin Proc 1981; 56: 51-54.
  • Edlich RF, Panek PH, Rodheaver GT, Turnbull VG, Kurtz LD, Edgerton MT: Physical and chemical configuration in the development of surgical infection. Ann Surg 1973; 177: 679-688.
  • Eleck SD, Conen PE: The virulence of Staphylococcus pyogenes for man: study of the problems of wound infection. Br J Exp Pathol 1957; 38: 573-586.
  • England SP, Stern SH, Insall JN, Windsor RE: Total knee arthroplasty in diabetes mellitus. Clin Orthop 1990; 260: 130-134.
  • Evard J, Doyan F, Acar JF, Salord JC, Mazas F, Flamant R: Two day cefamandole versus five-day cefazolin prophylaxis in 965 total hip replacements. Int Orthop 1988; 12: 69-73.
  • Fernandez MC, Gottlieb M, Menitove JE: Blood transfusion and postoperative infection in orthopaedic surgery. Transfusion 1992; 32: 318-322.
  • Fraise AP: Guidelines for the control of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1998 Sep;42(3):287-9.
  • Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA II, Coventry MB: Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg 1977; 59-A: 847-855.
  • Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AMM, et al: Prophylactic mupirocin could reduce orthopaedic wound infections; 1.044 patients treated with mupirocin compared with 1.260 historical controls. Acta Orthop. Scand. 1998; 69(4): 412-4.
  • Gherini S, Vaughn BK, Lombardi AV, Mallory TH: Delayed wound healing and nutritional deficiencies after total hip arthroplasty. Clin Orthop 1993; 293: 188-195.
  • Gillespie WJ: Infection in total joint replacement. Infect Dis Clin North Am 1990; 4: 465-484.
  • Glynn MK, Sheehan JM: An analysis of the causes of deep infection after hip and knee arthroplasties. Clin Orthop 1983; 178: 202-206.
  • Gogan TJ, Dorey F, Rollin J, Amstutz HC :Deep sepsis following total knee arthoplasty. J Bone Joint Surg-Am 1986; 68: 226.
  • Greenough CG: An investigation into contamination of operative suction. J Bone Joint Surg 1986; 68-B: 151-153.
  • Gristina AG: Biomaterial-centered infection: Microbial adhesion versus tissue integration. Science 1987; 237: 1588-1595.
  • Gross PA, Barrett TL, Dellinger EP, et al: Quality standard for antimicrobial prophylaxis in surgical procedures. Clinical Infect Dis 1994; 18: 421.
  • Hanssen AD, Fitzgerald RH Jr: Infection following primary cemented and uncemented total hip and total knee arthroplasty. Read at the 58th Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, California, March 9, 1991.
  • Hanssen AD: Prevention of deep periprosthetic infection. Instructional course lecture at the 65th Annual Meeting of the American Academy of Orthopaedic Surgeons, New Orleans, Louisiana, 1998.
  • Hanssen AD: The infected total hip arthroplasty. In Reconstructive surgery of the joint, Morrey BF ed, 1996; 90, 1229-1246.
  • Heath AF: Antimicrobial prophylaxis for arthroplasty and total joint replacement: discussion and review of published clinical trials. Pharmacotherapy 1991; 11: 157-163.
  • Heydemann JS, Nelson CL: Short-term preventative antibiotics. Clin Orthop 1986; 205: 184-187.
  • Hill C, Flamant R, Mazas F, Evrard J: Prophylactic cafazolin versus placebo in total hip replacement. Lancet 1981; 1: 795-797.
  • Jensen JE, Jensen TG, Smith TK, Johnston DA, Dudrick SJ: Nutrition in orthopaedic surgery. J Bone Joint Surg 1982; 64-A: 1263-1272.
  • Jerry GJ, Rand JA, Ilstrup D: Old sepsis prior to total knee arthroplasty. Clin Orthop 1988; 236: 135.
  • Johnston DH, Fairclough JA, Brown EM, Morris R: The rate of skin recolonization after surgical preparation: four methods compared. Br J Surg 1987; 74: 64.
  • Kendall RW, Duncan CP, Beauchamp CP: Bacterial growth on antibiotic-loaded acrylic cement. A prospective in vivo retrieval study. J Arthropl 1995 Dec;10(6):817-22
  • Katz S, Izhar M, Mirelman D: Bacterial adherence to surgical sutures: a possible factor in suture induced infection. Ann Surg 1981; 194: 35-41.
  • Letts RM and Doermer E: Conversation in the operating theater as a cause of airborne bacterial contamination. J. Bone Joint Surg 1983; 65-A, 357-362.
  • Lidwell OM, Lowbury EJL, Whyte W, Blowers R, Stanley SJ, Lowe D: Effect of ultra-clean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomized study. Br Med J 1982; 285: 10-14.
  • Marotte JH, Lord GA, Blanchard JP, et al: Infection rate in total hip arthroplasty as a function of air cleanliness and antibiotic prophylaxis. Ten-year experience with 2,384 cementless Lord Madreporic prostheses. J Arthroplasty 1987; 2: 77-82.
  • Mauerhan DR, Nelson CL, Smith D, et al: Prophylaxis against infection in total joint arthroplasty. One day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg 1994; 76-A: 39-45.
  • Menon TJ, Thjellesen D, Wroblewski BM: Charnley low-friction arthroplasty in diabetic patients. J Bone Joint Surg 1983; 65-B: 580-581.
  • Mitchell NJ, Hunt S: Surgical face masks in modern operating rooms—a costly and unnecessary ritual? J Hosp Infect 1991; 18: 239-242.
  • Moeckel B, Huo MH, Salvati EA, Pellicci PM: Total hip arthroplasty in patients with diabetes mellitus. J Arthroplasty 1993; 8: 279-284.
  • Moylan JA, Fitzpatrick KT, Davenport KE: Reducing wound infections: Improved gown and drape barrier performance. Arch Surg 1987; 122: 152-157.
  • Murphy P, Heal JM, Blumberg N: Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusions 1991; 31: 212-217.
  • Naylor PT, Myrvik QN, Gristina A: Antibiotic resistance of biomaterial-adherent coagulase-negative and coagulase-positive staphylococci. Clin Orthop 1990; 261: 126-133.
  • Nelson CL: Prevention of sepsis. Clin Orthop 1987; 222: 66-72.
  • Nelson CL: The prevention of infection in total joint replacement surgery. Rev Infect Dis 1987; 9: 613.
  • Nelson CL : Prevention of deep periprosthetic infection. Instructional course lecture at the 65th Annual Meeting of the American Academy of Orthopaedic Surgeons, New Orleans, Louisiana, 1998.
  • Nelson CL : Antibiotics for the practicing orthopaedic surgeon. Instructional course lecture at the 66th Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, California, 1999.
  • Nelson JP, Glassburn AR, Talbott RD, McElhinney JP: Clean room operating rooms. Clin Orthop 1973; 96: 179-187.
  • Nelson JP, Fitzgerald RH Jr, Jaspers MT, Little JW: Editorial. Prophylaxis coverage in arthroplasty patients. J Bone Joint Surg 1990; 72-A: 1.
  • Norden CW: Antibiotic prophylaxis in orthopaedic surgery. Rev Infect Dis 1991; S842-S846.
  • Oga M, Arizono T, Sugioka Y: Inhibition of bacterial adhesion by tobramycin-impregnated PMMA bone cement. Acta Orthop Scand 1992; 63: 301-304.
  • Osmon DR: Prevention of deep periprosthetic infection. Instructional course lecture at the 65th Annual Meeting of the American Academy of Orthopaedic Surgeons, New Orleans, Louisiana, 1998.
  • Osmon DR: Antibiotics for the practicing orthopaedic surgeon. Instructional course lecture at the 66th Annual Meeting of the American Academy of Orthopaedic Surgeons, Anaheim, California, 1999.
  • Papagelopoulus P: Long term outcome and survivorship analysis of primary total knee arthroplasty in patient with diabetes mellitus. Clin Orthop 1996; 330:124.
  • Park SK, Brody JI, Wallace HA, Blakemore WS: Immunosuppressive effect of surgery. Lancet 1971; 1: 53-55.
  • Perhala RS, Wilke WS, Clough JD, Segal AM :Local infectious complication following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991; 34(2):146.
  • Periti P, Jacchia E: Ceftriaxone as short term antimicrobial chemoprophylaxis in orthopaedic surgery: a 1-year multicenter follow-up. Eur. Surg. Res., 1989; 21(suppl 1): 25-32.
  • Persson U, Persson M, Malchau H : The economics of preventing revisions in total hip arthroplasty. Acta Orthop. Scand 1999; 70 (2): 163-9.
  • Petty, W: The effect of methylmethacrilate on bacterial phagocytosis and killing by human polymorphonuclear leukocytes. J. Bone Joint Surg. 1978; 60-A: 752-757.
  • Petty W, Spanier s, Shuster JJ: The influence of skeletal implants on the incidence of infection. J. Bone Joint Surg. 1985; 67-A: 1236-1244.
  • Petty W, Spanier s, Shuster JJ: Prevention of infection after total joint replacement. Experiments with a canine model. J. Bone Joint Surg. 1988; 70-A: 536-539.
  • Poss R, Thornhill TS, Ewald FC, et al: Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop 1984; 182: 117-126.
  • Rand JA, Bryan RS, Morrey BF, et al: Management of infected total knee arthoplasty. Clin Orthop 1986; 205:75.
  • Rand JA: Evaluation and management of infected total knee arthoplasty. Semin Arthroplasty 1994; 5(4):178.
  • Rand JA: Sepsis following total knee arthroplasty. New York: Raven press 1993; 349.
  • Ritter MA, Eitzen H, French ML, Hart JB: The operating room environment as affected by people and surgical mask. Clin Orthop 1975; 111: 145-150.
  • Ritter MA, Keating EM, Faris PM: Closed wound drainage in total hip or knee replacement. A prospective, randomized study. J Bone Joint Surg 1994; 76-A: 35-38.
  • Rosenstein BD, Wilson FC, Funderbunk CH: The use of Bacitracin irrigation to prevent infection in postoperative wounds. An experimental study. J Bone Joint Surg 1989; 71-A: 427-430.
  • Salvati EA, Robinson RP, Zeno SM, Koslin BL, Brause BD, Wilson PD Jr: Infection rates after 3,175 total knee replacements with and without a horizontal unidirectional filtered air-flow system. J Bone Joint Surg 1982; 64-A: 525-535.
  • Sanders R, Fortin P, Ross E, Helfet D: Outer gloves in orthopaedic procedures. Cloth compared with latex. J Bone Joint Surg 1990; 72-A: 914-917.
  • Sanderson PJ. Prophylacis in orthopaedic implant surgery-should we use a glycopeptide? J Antimicrob Chemother 1998; 41: 322-325.
  • Schmalzried TP, Amstutz HC, Au MK, Dorey FJ: Etiology of deep sepsis in total hip arthroplasty. The significance of hematogenous and recurrent infection. Clin Orthop 1992; 280: 200-207.
  • Sharp WV, Belden TA, King PH, Teague PC: Suture resistance to infection. Surgery 1982; 91: 61-63.
  • Smith TK: Nutrition: Its relationship to orthopaedic infections. Orthop Clin North Am 1991; 22: 373-377.
  • Soave R, Hirsh JC, Salvati EA, Brause BD, Roberts RB: Comparison of ceforanide and cephalothin prophylaxis in patients undergoing total joint arthroplasty. Orthopaedics 1986; 9: 1657-1660.
  • Strange-Vognsen HH, Klareskov B: Bacteriologic contamination of suction tips during hip arthroplasty. Acta Orthop Scand 1988; 59: 410-411.
  • Surin VV, Sundholm K, Backmann L: Infection after total hip replacement with special reference to a discharge from the wound. J Bone Joint Surg 1983; 65-B: 412-418.
  • Taylor GJS, Leeming JP, Bannister GC: Effect of antiseptic, ultraviolet light and lavage on airborne bacteria in a model wound. J Bone Joint Surg 1993; 75-B: 724-730.
  • Walter CW, Kundsin RB: The airborne component of wound contamination and infection. Arch Surg 1973; 107: 588-595.
  • Wilson MG, Kelley K, Thornhill TS: Infection as a complication of total knee-replacement arthroplasty: risk factors and treatment in sixty-seven cases. J Bone Joint Surg 1990; 72A: 878.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.